Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells

Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells

Liver inflammation represents a major clinical problem in a wide range of pathologies. Among the strategies to prevent liver failure, dexamethasone (DXM) has been widely used to suppress inflammatory responses. The use of nanocarriers for encapsulation and sustained release of glucocorticoids to liv...

Full description

Bibliographic Details
Main Authors: Carolina Medina-Montano, Ignacio Rivero Berti, Rocío C. Gambaro, María José Limeres, Malin Svensson, Gisel Padula, Cecilia Y. Chain, José Sebastián Cisneros, Guillermo R. Castro, Stephan Grabbe, Matthias Bros, Stephan Gehring, German A. Islan, Maximiliano L. Cacicedo
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
glucocorticoids
lipid nanoparticles
liver inflammation
liver immunology
autoimmune hepatitis
dexamethasone
Online Access:https://www.mdpi.com/1999-4923/14/8/1611

Internet

https://www.mdpi.com/1999-4923/14/8/1611

Similar Items